CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
86 hedge funds and large institutions have $131M invested in Cascadian Therapeutics, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 26
Holders
86
Holding in Top 10
1
Calls
$2.1M
Puts
$686K
Top Buyers
| 1 | +$5.06M | |
| 2 | +$2.78M | |
| 3 | +$2.04M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.04M |
| 5 |
D.E. Shaw & Co
New York
|
+$862K |
Top Sellers
| 1 | -$1.1M | |
| 2 | -$811K | |
| 3 | -$782K | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$648K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$580K |